Patients with unresectable hepatocellular carcinoma beyond Milan criteria: Should we perform transarterial chemoembolization or liver transplantation?

Transplantation Proceedings

Volumn 42, Issue 3, 2010, Pages 821-824

  Kim, J M ^a   Kwon, C H D ^a   Joh, J W ^a   Kim, S J ^a   Shin, M ^a   Kim, E Y ^a   Moon, J I ^a   Jung, G O ^a   Choi, G S ^a   Lee, S K ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE;

ARTICLE; BLOOD; CHEMOEMBOLIZATION; FEMALE; HEMATOCRIT; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVER TUMOR; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; MORTALITY; PATIENT SELECTION; RETROSPECTIVE STUDY; SURVIVAL RATE; THROMBOCYTE COUNT; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL;

ALANINE TRANSAMINASE; ALPHA-FETOPROTEINS; ASPARTATE AMINOTRANSFERASES; BLOOD UREA NITROGEN; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HEMATOCRIT; HUMANS; INTERNATIONAL NORMALIZED RATIO; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; PLATELET COUNT; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77955497082     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.02.027     Document Type: Conference Paper

References (28)

1. A. Sangiovanni, E. Del Ninno, and P. Fasani Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance Gastroenterology 126 2004 1005
2. T.J. Vogl, N.N. Naguib, and N.E. Nour-Eldin Review on transarterial chemoembolization in hepatocellular carcinoma: Palliative, combined, neoadjuvant, bridging, and symptomatic indications Eur J Radiol 72 2008 517
3. J.M. Llovet, and J. Bruix Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival Hepatology 37 2003 429
4. J.M. Llovet, M.I. Real, and X. Montana Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 2002 1734
5. M. Silva, A. Moya, and M. Berenguer Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma Liver Transpl 14 2008 1449
6. V. Mazzaferro, E. Regalia, and R. Doci Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693
7. F.Y. Yao, L. Ferrell, and N.M. Bass Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival Hepatology 33 2001 1394
8. S. Roayaie, J.S. Frischer, and S.H. Emre Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters Ann Surg 235 2002 533
9. H.A. Edmondson, and P.E. Steiner Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies Cancer 7 1954 462
10. J.N. Vauthey, G.Y. Lauwers, and N.F. Esnaola Simplified staging for hepatocellular carcinoma J Clin Oncol 20 2002 1527
11. G. Pelletier, M. Ducreux, and F. Gay Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial Groupe CHC J Hepatol 29 1998 129
12. C.M. Lo, H. Ngan, and W.K. Tso Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 2002 1164
13. M. Lesurtel, B. Mullhaupt, and B.C. Pestalozzi Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysis Am J Transplant 6 2006 2644
14. F.Y. Yao, R.K. Kerlan Jr., and R. Hirose Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis Hepatology 48 2008 819
15. W.C. Chapman, M.B. Majella Doyle, and J.E. Stuart Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation Ann Surg 248 2008 617
16. W. De Luna, D.Y. Sze, and A. Ahmed Transarterial chemoinfusion for hepatocellular carcinoma as downstaging therapy and a bridge toward liver transplantation Am J Transplant 9 2009 1158
17. E. Regalia, J. Coppa, and A. Pulvirenti Liver transplantation for small hepatocellular carcinoma in cirrhosis: analysis of our experience Transplant Proc 33 2001 1442
18. M.E. Schwartz, F. D'Amico, and A. Vitale Liver transplantation for hepatocellular carcinoma: Are the Milan criteria still valid? Eur J Surg Oncol 34 2008 256
19. J.M. Llovet, A. Burroughs, and J. Bruix Hepatocellular carcinoma Lancet 362 2003 1907
20. F.Y. Yao, and J.P. Roberts Applying expanded criteria to liver transplantation for hepatocellular carcinoma: too much too soon, or is now the time? Liver Transpl 10 2004 919
21. S.A. Shah, J.C. Tan, and I.D. McGilvray Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma Transplantation 81 2006 1633
22. N. Onaca, G.L. Davis, and R.M. Goldstein Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation Liver Transpl 13 2007 391
23. F.Y. Yao, L. Ferrell, and N.M. Bass Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria Liver Transpl 8 2002 765
24. J.P. Duffy, A. Vardanian, and E. Benjamin Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA Ann Surg 246 2007 502
25. F.Y. Yao, L. Xiao, and N.M. Bass Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging Am J Transplant 7 2007 2587
26. M. Malago, X. Rogiers, and C.E. Broelsch Liver splitting and living donor techniques Br Med Bull 53 1997 860
27. C.L. Berg, B.W. Gillespie, and R.M. Merion Improvement in survival associated with adult-to-adult living donor liver transplantation Gastroenterology 133 2007 1806
28. T. Ito, Y. Takada, and M. Ueda Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation Liver Transpl 13 2007 1637